Brief: ASIT Biotech On Track For Readout Phase III Grass Pollen Allergy Study

European Medical Solutions SA

26/09/2019 06:22

Sept 26 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH FIRMLY ON COURSE FOR READOUT OF PHASE III
CLINICAL
STUDY IN GRASS POLLEN ALLERGY
    * IS COLLABORATING WITH ICON PLC (CRO) TO FINALIZE DATA
COLLECTION
BEFORE DATABASE LOCK AND STATISTICAL ANALYSES
    * PASSED LAST PATIENT LAST VISIT (LPLV) MILESTONE IN PIVOTAL
GP-ASIT+ PHASE III TRIAL
    * REMAINS ON TRACK TO DELIVER PRIMARY EFFICACY RESULTS IN
DECEMBER
2019
    * COMPANY REMAINS ON TRACK TO DELIVER TOP-LINE EFFICACY
RESULTS ON
GP-ASIT+ IN DECEMBER 2019

Source text for Eikon:  ID:nBw9d2dcGa 
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))